Remote emerging disease intelligence-network (redi-net) phase III - r & d effort (BAA)
Ended Definitive Contract Awarded Last action
- Contract number
- HT942523C0059
- Awardee
-
University Of Notre Dame DU Lac UEI FPU6XGFXMBE9 Part of University Of Notre Dame DU Lac
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $3,899,628
Award facts
- Contract value 100% obligated
- $3,899,628.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Notre Dame, IN 46556, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$17,643 | |
| Original award | $3,917,271 |
About this award
The University of Notre Dame DU Lac was awarded a $3.9M cost-plus-no-fee definitive contract on September 1, 2023, for the Remote Emerging Disease Intelligence-Network (REDI-NET) Phase III research and development effort under a broad agency announcement. The contract, which is scheduled for completion on January 29, 2025, will be performed at Notre Dame's Research Division facilities in Notre Dame, Indiana. The work supports the Medical Command, a defense-focused component of the U.S. government, and does not include a set-aside designation, indicating competitive award to the university based on technical merit and capability.
This Phase III effort represents a continuation of Notre Dame's involvement in the REDI-NET program, leveraging the university's established expertise in advanced research and development across scientific and technological domains. As a private Catholic research institution with a robust federal contract portfolio spanning agencies including the Department of Defense, NASA, and the National Institutes of Health, Notre Dame brings substantial capabilities in research infrastructure and interdisciplinary technical expertise to support emerging disease intelligence initiatives. The cost-no-fee contract structure indicates reimbursement for allowable costs without additional profit margin, a common arrangement for university-based research partnerships with defense and medical research objectives.
Quick answers
Who was awarded contract HT942523C0059?
HT942523C0059 was awarded to University Of Notre Dame DU Lac by Defense Health Agency (Department of Defense) on September 1, 2023.
How much is contract HT942523C0059 worth?
The government has obligated $3,899,628 on HT942523C0059.
Which agency awarded contract HT942523C0059?
Defense Health Agency (Department of Defense) awarded HT942523C0059, with funding from Medical Command (Department of the Army).
Was contract HT942523C0059 competed?
The extent of competition for HT942523C0059 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award